The Future of Cardiac Monitoring . . .

The makers of the CardioSen’C are light years ahead of their competition in the development of advanced cardiac monitoring devices.

The CardioPocket™ is an elegant leather wallet suitable for carrying bills, credit cards, identification cards and the like. In addition, it serves as a 1-lead (rhythm strip) ECG transmitter for diagnosing heart rhythm disturbances. The ECG transmitter inside the wallet encourages the subscriber to contact the Monitor Center immediately when discomfort occurs. By simply placing the wallet against the chest and using any telephone or cellular phone, the user can transmit within seconds a real-time ECG strip to the remote monitor center for immediate consultation.

The TeleMarker™ (Patent Pending) is a patient-level transtelephonic cardiac blood testing device. The TeleMarker™ obtains a precise blood sample and performs an accurately timed, laboratory- type analysis of multiple critical “cardiac markers”. The visual test results are then automatically transmitted over the telephone to a qualified medical monitoring center, aiding in the care of the user.
It is well known that preliminary diagnosis of acute myocardial infarction (MI) is based on the presence of multiple key parameters including suggestive MI symptoms, abnormal ECG changes and laboratory analysis of elevations in the cardiac markers. The addition of the TeleMarker™ now enables the SHL monitoring center to receive all three critical diagnostic parameters directly from the patient’s home. The TeleMarker™ aids in the proper diagnosis thus decreasing unnecessary false hospitalizations while enhancing the user’s peace of mind and contributing to the quality of life.

LidoPen® auto-injector to self-administer lidocaine while the ambulance is en route. The LidoPen® can be crucial for saving a subscriber’s life in cases where a severe arrhythmia is diagnosed by Monitor Center staff. LidoPen® is an automatic, patient-administered syringe containing a single 300-mg. dose of Lidocaine. Lidocaine provides immediate, reliable treatment to patients suffering from ventricular tachycardia until professional help arrives.
LidoPen® is designed to be used as part of a comprehensive remote cardiac monitoring and diagnostic service. The patient activates the Lidocaine self-injector only upon direct instructions from a physician at the monitor center, following definite diagnosis of ventricular tachycardia. The patient transmits an ECG reading over the phone from a patient-level portable ECG transmitter, such as Shl’s CardioBeeper® CB-12/12. A trained medical staff uses the ECG waveform together with the patient’s self-described symptoms to reach a remote diagnosis in real-time.

Check out SHL’s full line of telemedicine products . . .